EUCTR2020-004614-35-DK进行中（未招募）1 期
Treatment with SGLT-2 inhibitor for postoperative hyperglycemia in acute abdominal surgery – a randomized trial
Ismail Gögenur0 个研究点目标入组 24 人开始时间: 2021年3月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Admitted to the ward after acute abdominal surgery (ASAP patient at Slagelse Hospital, OMEGA patient at Zealand University Hospital)
- •-At least two independent measurements of blood glucose above 7.7mmol/l within the first 48 hours after surgery
- •-Age of 18 to 85
- •-Must be able to understand and sign informed content
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 12
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 12
排除标准
- •-Patients diagnosed with diabetes mellitus
- •-Impaired kidney function (eGFR < 45mL/min)
- •-Severe liver disease (defined as transaminases above X 3 normal levels)
- •-Acute pancreatitis within the last two months or a history of chronic pancreatitis
- •-Participation in another pharmacological intervention trial
- •-Predictable poor compliance (for instance mentally impaired)
- •-Pregnancy or lactation (fertile women must have a negative serum or urine pregnancy test to participate)
- •-Allergy to study medication
研究者
相似试验
Unknown
2 期
Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized TrialPostoperative HyperglycemiaStress HyperglycemiaNCT05314725Zealand University Hospital24
招募中
1 期
SGLT2 inhibitor TrEatment iN patients awaiting cOronary arTery bYpass surgery to reduce Post-opErative atrial fibrillation and kidney injury (STENOTYPE trial).Onset of Atrial Fibrillation and Acute Kidney Injury after coronary artery bypass surgery (GABG)CTIS2023-505375-75-00Region Oerebro Laen800
进行中（未招募）
不适用
Combination of SGLT2 inhibitor and Intensive Exercise in Diabetes.JPRN-jRCTs071180050Yoshihiro Ogawa146
招募中
4 期
Effects of SGLT-2 inhibitors for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.on-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus.JPRN-UMIN000018913Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine50
已完成
不适用
The efficacy and safety of SGLT2 inhibitor for non alcholic fatty liver disease in Japanese patients with type 2 diabetesJPRN-UMIN000016306Tokyo Medical and Dental University50